Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stockfool.comThis surgical robotics firm develops minimally invasive systems for urologic procedures, targeting hospitals and specialty clinics.
PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Whybenzinga.comPROCEPT BioRobotics (
NASDAQ: PRCT) shares down on Q4 2025 results and updated revenue guidance. Q1 sales expected at $79-82 million.
After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Millionfool.comThis healthcare technology firm develops robotic surgical systems for minimally invasive urology procedures targeting BPH treatment.
2 Robotics Stocks Riding the Sensor and Medical Boomfool.comThe robotics infrastructure layer is delivering explosive returns.
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Declinechartmill.comPROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces investor concerns over rising costs and ongoing losses.
